SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0000899140-13-000522
Filing Date
2013-10-08
Accepted
2013-10-08 12:27:04
Documents
2
Group Members
DR. ALEXANDER DENNERDR. RICHARD MULLIGANSARISSA CAPITAL DOMESTIC FUND LPSARISSA CAPITAL OFFSHORE MASTER FUND LP

Document Format Files

Seq Description Document Type Size
1 a10496652a.htm SC 14D9 76550
2 PRESS RELEASE a10496652b.htm EX-1 12723
  Complete submission text file 0000899140-13-000522.txt   91052
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Subject) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-48769 | Film No.: 131140754
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD 3RD FLOOR GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD 3RD FLOOR GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9